<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067518/" ref="ordinalpos=3575&amp;ncbi_uid=6284651&amp;link_uid=PMC4067518" image-link="/pmc/articles/PMC4067518/figure/F8/" class="imagepopup">Figure 8.  From: Molecular aspects of development and regulation of endometriosis. </a></div><br /><div class="p4l_captionBody"><b>TGF-β/SMAD signaling pathway.</b> The SMAD proteins are the only family of transcription factors known to propagate TGF-β signals. Lerdelimumab (a recombinant human IgG4 targeting TGF- β2) and Metelimumab (a human monoclonal IgG4 against TGF- β1) can inhibit TGF-β signaling. </div></div>